GN

Gita Nagjibhai Patel

Active Director Director DIN 09195747
DIN 09195747 First appointment Jun 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Gita Nagjibhai Patel

Data last updated:

Gita Nagjibhai Patel is a Director at Octawings Healthcare Private Limited (since 2021). The company operates in Chemicals.

DIN 09195747
Primary Designation Director
Industry Chemicals
First Appointment 07 Jun 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Octawings Healthcare Private Limited U24299GJ2021PTC123101
Director07 Jun 20212021Active

Board colleagues of Gita Nagjibhai Patel

Directorship timeline

Open interactive timeline →
Octawings Healthcare Private Limited
Premium access

Shareholding and investment profile for Gita Nagjibhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gita Nagjibhai Patel

Gita Nagjibhai Patel currently holds 1 directorship: Octawings Healthcare Private Limited (Director, since 07 Jun 2021).

Gita Nagjibhai Patel was first appointed on 07 Jun 2021 as Director at Octawings Healthcare Private Limited.

The current boards of Gita Nagjibhai Patel's companies include Nagjibhai Patel (Octawings Healthcare Private Limited), Naresh Mansukhbhai Vasoya (Octawings Healthcare Private Limited), Yogeshkumar Parmar (Octawings Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available